HomeComparePETFF vs PFE

PETFF vs PFE: Dividend Comparison 2026

PETFF yields 12.91% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PETFF wins by $414.33M in total portfolio value
10 years
PETFF
PETFF
● Live price
12.91%
Share price
$0.55
Annual div
$0.07
5Y div CAGR
62.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$414.38M
Annual income
$371,149,854.13
Full PETFF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — PETFF vs PFE

📍 PETFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPETFFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PETFF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PETFF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PETFF
Annual income on $10K today (after 15% tax)
$1,097.69/yr
After 10yr DRIP, annual income (after tax)
$315,477,376.01/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PETFF beats the other by $315,454,247.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PETFF + PFE for your $10,000?

PETFF: 50%PFE: 50%
100% PFE50/50100% PETFF
Portfolio after 10yr
$207.22M
Annual income
$185,588,532.34/yr
Blended yield
89.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PETFF
No analyst data
Altman Z
1.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PETFF buys
0
PFE buys
0
No recent congressional trades found for PETFF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPETFFPFE
Forward yield12.91%6.20%
Annual dividend / share$0.07$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR62.8%13.2%
Portfolio after 10y$414.38M$51.1K
Annual income after 10y$371,149,854.13$27,210.54
Total dividends collected$411.03M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PETFF vs PFE ($10,000, DRIP)

YearPETFF PortfolioPETFF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,802$2,102.40$9,161$701.38+$3.6KPETFF
2$17,794$4,095.22$8,610$859.79+$9.2KPETFF
3$27,699$8,660.13$8,366$1,081.25+$19.3KPETFF
4$50,150$20,511.55$8,483$1,405.66+$41.7KPETFF
5$110,163$56,502.60$9,084$1,907.24+$101.1KPETFF
6$306,719$188,844.48$10,418$2,732.78+$296.3KPETFF
7$1,128,170$799,980.56$13,007$4,193.56+$1.12MPETFF
8$5,684,109$4,476,966.93$18,010$7,005.87+$5.67MPETFF
9$40,401,609$34,319,612.98$28,216$12,979.89+$40.37MPETFF
10$414,379,576$371,149,854.13$51,081$27,210.54+$414.33MPETFF

PETFF vs PFE: Complete Analysis 2026

PETFFStock

PTT Public Company Limited, together with its subsidiaries, operates as a petroleum and petrochemical company in Thailand, other Asian countries, Europe, the United States, and internationally. It operates through Upstream Petroleum and Natural Gas Business Group, Downstream Petroleum Business Group, and New Business and Infrastructure Group. The company is involved in the exploration and production of petroleum; and natural gas procurement, pipeline transmission, distribution, and separation activities. In addition, it engages in the exploration, production, and distribution of coal; and marketing of petroleum products and lube oil through an operating system of procurement, storage, and distribution of products, as well as the retail business at service stations. Further, the company imports and exports petroleum and petrochemical products, as well as other related products; produces and distributes electricity, steam, and water for industrial purpose; and offers project management, human resource support, petroleum related technology, consultant management, technical consultant for electricity businesses, petrol station and convenience store management, factory maintenance and engineering, oil and gas, safety and environmental, and business services, as well as services for the storage and handling of liquid chemicals. Additionally, it invests in liquefied natural gas business; produces and distributes chilled water/constructs and installs electricity generating systems; develops electricity power production projects; develops, markets, and distributes polymers products, by products, and other polymers-related products; develops real estate properties; operates vocational schools; and manufactures and distributes biochemical products, paraxylene, and industrial coatings and additives, as well as engages in the transportation, warehouse, and bagging packing management of polyethylene. The company was founded in 1978 and is headquartered in Bangkok, Thailand.

Full PETFF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PETFF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PETFF vs SCHDPETFF vs JEPIPETFF vs OPETFF vs KOPETFF vs MAINPETFF vs JNJPETFF vs MRKPETFF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.